Boxum, Marit
Voetterl, Helena
van Dijk, Hanneke
Gordon, Evian
DeBeus, Roger
Arnold, L. Eugene
Arns, Martijn
Article History
First Online: 10 June 2024
Declarations
:
: Dr Gordon is founder and Chairman for Brain Resource Ltd. Dr DeBeus has received research funding from the National Institute of Mental Health, has served on the Board of Directors for the International Society for Neurofeedback and Research, and has a clinic in North Carolina where he performs neurofeedback, among other clinical services. Dr. Arnold has received research funding from Supernus Pharmaceuticals, Roche/Genentech Pharmaceuticals, Otsuka Pharmaceuticals, Axial, Yamo, Maplight, and YoungLiving Essential Oils and National Institute of Health (USA, R01 MH 100144), has consulted with Pfizer Pharmaceuticals, Yamo, and CHADD, and been on advisory boards for Otsuka and Roche/Genentech. Dr. Arns holds equity/stock in neurocare and Sama Therapeutics, serves as consultant to Synaeda, Sama Therapeutics and Roche and is named inventor on patents and intellectual property but receives no royalties.All other authors report no biomedical financial interests or potential conflicts of interest.